AstraZeneca PLC’s U.S. shares tumbled $4.99, or 7.5 percent, to $61.38, Thursday on the New York Stock Exchange after the London-based drug maker said it is discontinuing development of an experimental stroke drug.
The company said it was halting development of NXY-059, also known as Cerovive, after a late-stage clinical trial showed it failed to significantly […]
TALLAHASSEE · Bobby Bowden still thinks he has numbers on his side, not that he’s keeping count.
“I know there are people upset,” he said Monday after Florida State’s loss to Boston College on Saturday effectively eliminated the Seminoles from Atlantic Coast Conference title contention. “It ain’t like there’s a million out there.”
LocalLinks
He doesn’t care exactly […]
WILMINGTON, Del. — AstraZeneca announced that the US Food and Drug Administration (FDA) has approved a new indication for the prescription proton pump inhibitor NEXIUM® (esomeprazole magnesium) for the treatment of Zollinger-Ellison Syndrome (ZES). NEXIUM already is indicated for the treatment of gastroesophageal reflux disease (GERD) in adults and children ages 12 to 17, and […]
Drug developer AstraZeneca Plc. said late Thursday the Food and Drug Administration approved Nexium for use in treating Zollinger-Ellison Syndrome, a rare disorder.
Nexium, a proton pump inhibitor, is already approved to treat gastroesophageal reflux disease in adults and children between the ages of 12 and 17. Zollinger-Ellison Syndrome, or ZES, causes tumors in the pancreas […]
A trial of a new male contraceptive is being expanded after American men rushed to sign up.
The Intra Vas Device (IVD), which is designed to be an alternative to a vasectomy, consists of tiny silicone plugs inserted into the tubes through which sperm travel.
It was effective in all cases in a pilot study of 30 […]